Capital World Investors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital World Investors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2021$42,655,000
+14.8%
1,457,280
-0.0%
0.01%
+16.7%
Q3 2021$37,147,000
-27.2%
1,457,892
+0.1%
0.01%
-33.3%
Q2 2021$51,028,000
-14.0%
1,457,110
+0.0%
0.01%
-18.2%
Q1 2021$59,348,000
-5.8%
1,456,390
+0.1%
0.01%
-8.3%
Q4 2020$62,999,000
-21.4%
1,454,609
+0.1%
0.01%
-33.3%
Q3 2020$80,142,000
-12.6%
1,453,421
+0.1%
0.02%
-18.2%
Q2 2020$91,702,000
+23.6%
1,452,595
+0.0%
0.02%0.0%
Q1 2020$74,206,000
+99.7%
1,452,448
+210.7%
0.02%
+175.0%
Q4 2019$37,163,000
+101.6%
467,520
+23.0%
0.01%
+100.0%
Q3 2019$18,438,000
+119.1%
380,000
+137.5%
0.00%
+100.0%
Q2 2019$8,416,000
-0.6%
160,0000.0%0.00%0.0%
Q1 2019$8,469,000
+28.9%
160,0000.0%0.00%0.0%
Q4 2018$6,568,000
+8.0%
160,0000.0%0.00%
+100.0%
Q3 2018$6,080,000
-15.9%
160,0000.0%0.00%
-50.0%
Q2 2018$7,232,000
-6.4%
160,0000.0%0.00%0.0%
Q1 2018$7,728,000160,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 383,702$14,581,0007.71%
Perceptive Advisors 5,148,910$195,658,0005.23%
Grace Capital 312,514$11,876,0004.65%
NEXTHERA CAPITAL LP 549,231$20,871,0004.00%
Asymmetry Capital Management, L.P. 103,449$3,931,0003.63%
Camber Capital Management LP 2,075,000$78,850,0003.37%
Casdin Capital, LLC 440,000$16,720,0002.03%
EMORY UNIVERSITY 53,951$2,050,0001.34%
ArchPoint Investors 129,435$4,919,0001.34%
Ghost Tree Capital, LLC 150,000$5,700,0001.21%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders